Artificial Intelligence (AI) In Genomics Market Growth Accelerated By Rising Adoption Of AI In Precision Medicine
%20In%20Genomics%20Market.jpg)
Artificial Intelligence (AI) in Genomics Market
Artificial intelligence (AI) in genomics refers to the use of AI techniques to
analyze complex genomic and biomedical data and aid in disease diagnosis,
prognosis, and personalized treatment. AI enables detection of patterns,
prediction of outcomes, and discovery of insights by learning from large
datasets of genomic studies. The rising adoption of precision medicine has
accelerated the use of AI as it analyzes enormous genetic data to deliver
individually customized healthcare solutions. AI also aids in accelerating drug
discovery by drawing meaningful conclusions from massive genomic datasets.
The global Artificial Intelligence (AI) in Genomics
Market is estimated to be valued at US$
1.33 Bn in 2023 and is expected to exhibit a CAGR of 6.1% over the
forecast period 2024 to 2030, as highlighted in a new report published by
Coherent Market Insights.
Market key trends:
The growing adoption of precision medicine has been a major driver for the
increasing use of AI in genomics. Precision medicine involves the use of a
patient's genetic makeup to provide customized treatment and care. With the
ongoing decline in sequencing costs, a massive amount of genomic data is being
generated and the need to analyze this data comprehensively through AI
techniques is rising. AI algorithms can learn from large genomic datasets and
help physicians make informed treatment decisions based on a patient's unique
genetic profile. This is accelerating the growth of the AI in genomics market.
AI also aids in accelerating the drug discovery process by identifying
meaningful associations from vast genomic datasets which was not possible
through conventional methods. This key trend will continue to boost the demand
for AI in genomics solutions over the forecast period.
Segment Analysis
The global artificial intelligence (AI) in genomics market is dominated by
product and services segment. The product segment is further divided into NGS
workstations and systems, microarray workstations and systems, sequencing and
gene synthesis instruments and services. Among these, the NGS workstations and
systems sub-segment accounts for the largest share owing to increasing demand
for next-generation sequencing in the field of genomics. NGS deliver high
throughput, scalability, speed and accuracy in genomic analysis. Due to these
advantages, there is high demand for NGS instruments which is driving the
growth of this sub-segment.
Key Takeaways
The global Artificial
Intelligence (AI) In Genomics Market Demand is expected to witness high
growth.
Regional analysis: The North
America region currently dominates the global AI in genomics market and is
expected to maintain its dominance during the forecast period. The region has
presence of major players and availability of advanced healthcare
infrastructure. The growing government funding for genomic and AI projects is
also fueling market growth in North America.
Key players operating in the artificial intelligence (AI) in genomics market
are Thermo Fisher Scientific, F. Hoffmann-La Roche AG, Qiagen N.V, Hologic
Inc., Siemens Healthineers AG, BioMerieux SA, Abbott Laboratories, Bio-Rad
Laboratories Inc., Becton, Dickinson and Company, and Danaher Corporation
(Beckman Coulter, Inc.), among others.
Explore more
related article on this topic: https://www.newswirestats.com/artificial-intelligence-ai-is-transforming-genomics-to-accelerate-market/
For More Insights On
This Topic: https://captionssky.com/central-venous-catheter-market-in-the-u-s-an-overview/
Comments
Post a Comment